Bluejay Therapeutics, a private biopharmaceutical company focused on the development of cures for infectious diseases, has appointed Nancy Shulman, M.D., as chief medical officer, bringing over 20 years of clinical development experience with her to the company.   “Nancy is an experienced infectious disease clinician and expert clinical drug developer with successful track record in drug development including antivirals in both large pharmaceutical companies and startup biotech companies, and ...